Boardroom Alpha
Boardroom Alpha
FTLF · Current Report (Form 8-K) · Filed August 13, 2026

Fitlife Brands Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 13, 2026
Period
Aug 11, 2026
Ticker
FTLF
Accession
0001437749-26-027493
Boardroom Alpha · Filing insights

Stockholders elected directors and ratified auditors; company announced Q2 2026 results.

About Fitlife Brands Inc
Market cap
$94M
1Y TSR
−37.5%
Board grade
B
Sector
Consumer Defensive
CEO
Judd Dayton
Last annual meeting: Aug 11, 2026 · View full Fitlife Brands Inc profile →
ftlf20260813_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): August 11, 2026
 
Commission File Number: 000-52369
 
 
FitLife Brands, Inc.
(Exact name of registrant as specified in its charter.)
 
Nevada
20-3464383
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
 
5214 S. 136th StreetOmahaNebraska68137
(Address of principal executive offices)
 
(402991-5618
(Registrant's Telephone number)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock, par value $0.01 per 
share
FTLF
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
Emerging growth company ☐ 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
Item 2.02    Results of Operations and Financial Condition.
 
On August 13, 2026, FitLife Brands, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2026. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
 
Item 5.07    Submission of Matters to a Vote of Security Holders.
 
On August 11, 2026, the Company held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The matters voted upon at the Annual Meeting and the results of the voting are set forth below.
 
Proposal No. 1 Election of Directors
 
 
 
For
 
 
Withhold
 
Dayton Judd
 
6,473,347
 
 
7,871
 
Grant Dawson
 
6,404,721
 
 
76,497
 
Matt Lingenbrink
 
6,396,514
 
 
84,704
 
Seth Yakatan
 
6,392,827
 
 
88,391
 
Shannon Pappas
 
6,396,637
 
 
84,581
 
 
The Company’s Directors are elected by a plurality of the votes cast. Accordingly, each of the nominees named above were elected to serve on the Board of Directors until the 2027 Annual Meeting of Stockholders, or until their successors are elected and qualified.
 
Proposal No. 2 Ratification of Appointment of Auditors
 
 
 
For
 
 
Against
 
 
Abstain
 
Votes
 
8,279,628
 
 
119
 
 
5,251
 
 
The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, stockholders ratified the appointment of Weinberg & Company, P.A. as the Company’s independent auditors for the fiscal year ending December 31, 2026.
 
Item 7.01    Regulation FD Disclosure
 
See Item 2.02.
 
Disclaimer.
 
The information furnished pursuant to Item 2.02 and 7.01, including Exhibit 99.1, shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by referenced.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits Index
 
Exhibit No.
 
Description
99.1
 
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
FitLife Brands, Inc.
 
 
 
 
 
August 13, 2026
By:
/s/ Dayton Judd
 
 
 
Dayton Judd
 
 
 
Chief Executive Officer
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Fitlife Brands Inc (FTLF)

Reference

Frequently asked questions

When did Fitlife Brands Inc file this 8-K?
Fitlife Brands Inc (FTLF) filed this Current Report (Form 8-K) with the SEC on August 13, 2026. The accession number assigned by EDGAR is 0001437749-26-027493.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected directors and ratified auditors; company announced Q2 2026 results. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Fitlife Brands Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Fitlife Brands Inc has filed under CIK 1374328, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer